Drug induced acute dystonia misdiagnosed as hysteria;MEDIKAMENTINDUSERTE DYSTONIER MISTOLKET SOM HYSTERI

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 7, 1996, Pages 844-845

  Magnusson, Andres ^a   Opjordsmoen, Stein ^a   Dietrichs, Espen ^b  

^a Klinikk for Psykiatri   (Norway)

^b Nevrologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; CHLORPROMAZINE; DIAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT; ORPHENADRINE; OXAZEPAM; TETRABENAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CASE REPORT; DYSTONIA; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

ADRENERGIC UPTAKE INHIBITORS; ADULT; ANTIPSYCHOTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DYSTONIA; FEMALE; HALOPERIDOL; HUMANS; HYSTERIA; MALE; TETRABENAZINE;

EID: 0029987850     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. LeWitt PA. Dystonia caused by drugs. I: King J. Tsui C, Calne DB. red. Handbook of dystonia. New York: Marcel Dekker, 1995: 227-40.
2. Lingjærde O. Psykofarmaka. Oslo: Tano, 1988.
3. Sewell D, Jeste DV, McAdams LA, Bailey A, Harris MJ, Atkinson JH et al. Neuroleptic treatment of HIV-associated psychosis. Neuropsychopharmacology 1994; 10: 223-9.
4. Spina E, Sturiale V, Valvo S, Ancione M, Di Rosa AE, Meduri M et al. Prevalence of acute dystonic reactions associated with neuroleptic treatment with and without anticholinergic prophylaxis. Int Clin Psychopharmacol 1993; 8: 21-4.
5. Burke RE, Fahn S, Mayeux R, Weinberg H, Louis K, Willner JH. Tetrabebazine induces acute dystonic reactions. Ann Neurol 1985; 17: 200-2.
6. Addonizio G, Alexopoulos GS. Drug-induced dystonia in young and elderly patients. Am J Psychiatry 1988; 145: 869-71.
7. Aguilar EJ, Keshavan MS, Martinez-Quiles MD, Hemandez J, Gomez-Beneyto M, Schooler NR. Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry 1994; 151: 1819-21.
8. Khanna R, Das A, Damodaran SS. Prospective study of neuroleptic-induced dystonia in mania and schizophrenia. Am J Psychiatry 1992; 149: 511-3.
9. Harris MJ, Jeste DV, Gleghom A, Sewell DD. New-onset psychoses in HIV-infected patients. J Clin Psychiatry 1991; 52: 369-76.
10. Hriso E, Kuhn T, Masdeu J, Grundman M. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psychiatry 1991; 148: 1558-61.
11. Marotta R, Perry S. Early neuropsychological dysfunction caused by human immunodeficiency virus. J Neuropsychiatry 1989; 1: 225-35.
12. Miller D, Ricco M. Non-organic psychiatric and psychosocial syndromes associated with HIV-infection and disease. AIDS 1990; 4: 381-8.
13. Evans DL, Perkins DO. The clinical psychiatry of AIDS. Curr Opin Psychiatry 1990; 3: 96-102.
14. Perry S, Jacobsen P. Neuropsychiatric manifestations of AIDS-spectrum disorders. Hosp Community Psychiatry 1986; 37: 135-42.
15. Wolcott DL, Fawzy FI, Pasnau RO. Acquired immune deficiency syndrome (AIDS) and consultation-liason psychiatry. Gen Hosp Psychiatry 1985; 7: 280-92.
16. Sachdev P. Tardive and cronically recurrent oculogyric crises. Mov Disord 1993; 8: 93-7.
17. Matthews WB. Diseases of the nervous system. Oxford: Blackwell Scientific Publications, 1982: 315.
18. Erickson JD, Eiden LE. Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J Neurochem 1993; 61: 2314-7.
19. Haggendal J. The depletion and recovery of noradrenaline in the brain and some sympathetically innervated mammalian tissues after tetrabenazine. J Pharm Pharmacol 1968; 20: 364-7.
20. Neale R, Gerhardt S, Liebman JM. Effects of dopamine agonists, catecholamine depletors and cholinergic and GABA-ergic drugs on acute dyskinesias in squirrel monkeys. Psychopharmacology (Berl) 1984; 82: 20-6.
21. Jørgensen HA, Andreassen OA, Hole K. The relationship between motor effects in rats following acute and chronic haloperidol treatment. Psychopharmacology (Berl) 1994; 116: 89-92.